The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) has provided evidence-based guidelines for all stages of chronic kidney disease (CKD) and related complications since 1997. The 2015 update of the KDOQI Clinical Practice Guideline for Hemodialysis Adequacy is intended to...
This guideline covers diagnosing, assessing, managing and monitoring anaemia in people with chronic kidney disease. It aims to improve care for people with chronic kidney disease by specifying how to assess when their anaemia needs treating, and by making detailed recommendations on treatment with erythr...
This guideline covers the care and treatment of people with, or at risk of developing, chronic kidney disease. It aims to prevent or delay the progression of chronic kidney disease, reduce or prevent the development of complications, and reduce the risk of cardiovascular disease....
Górriz, J. L;
Gutiérrez, F;
Trullas, J. C;
Arazo, P;
Arribas, J. R;
Barril, G;
Cervero, M;
Cofan, F;
Domingo, P;
Estrada, V;
Fulladosa, X;
Galindo, M. J;
Gracia, S;
Iribarren, J. A;
Knobel, H;
López-Aldeguer, J;
Lozano, F;
MartÃnez-Castelao, A;
MartÃnez, E;
Mazuecos, M. A;
Miralles, C;
Montañés, R;
Negredo, E;
Palacios, R;
Pérez-ElÃas, M. J;
Portilla, J;
Praga, M;
Quereda, C;
Rivero, A;
SantamarÃa, J. M;
Sanz, J;
Miró, J. M.
OBJETIVO: Actualizar las recomendaciones sobre la evaluación y el manejo de la afectación renal en pacientes con infección por el virus de la inmunodeficiencia humana (VIH). MÉTODOS: Este documento ha sido consensuado por un panel de expertos del Grupo de Estudio de Sida (GESIDA) de la Sociedad EspaÃ...
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the screening, monitoring, and treatment of adults with stage 1 to 3 chronic kidney disease. METHODS: This guideline is based on a systematic evidence review eval...
Insuficiencia Renal Crónica/diagnóstico,
Insuficiencia Renal Crónica/tratamiento farmacológico,
Progresión de la Enfermedad,
Triaje,
Antagonistas de Receptores de Angiotensina/uso terapéutico,
Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico,
Antihipertensivos/uso terapéutico,
Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico,
Hipolipemiantes/uso terapéutico,
Gemfibrozilo/uso terapéutico,
Enfermedades Asintomáticas,
Quimioterapia Combinada,
Enfoque GRADE
This guideline covers managing hyperphosphataemia in children, young people and adults with stage 4 or 5 chronic kidney disease. It makes recommendations on dietary management and phosphate binders, to reduce variation in care and the risk of hyperparathyroidism for people with chronic kidney disease....
